1.
J Mycol Med
; 28(1): 218-221, 2018 Mar.
Article
in English
| MEDLINE
| ID: mdl-29132794
ABSTRACT
Saccharomyces cerevisiae is a common colonizer of the human gastrointestinal system as a benign organism. Enteral supplementation of this yeast as a probiotic product is effective in the treatment of antibiotic associated diarrhae. In rare occasions it can cause invasive infections. We present two fungemia cases in an intensive care unit following probiotic treatment containing S. boulardii. We are warning the safety of probiotic treatment in critically ill patients.
Subject(s)
Fungemia/etiology , Fungemia/microbiology , Intensive Care Units , Probiotics/adverse effects , Saccharomyces cerevisiae/isolation & purification , Adult , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Antifungal Agents/therapeutic use , Critical Illness , Diarrhea/microbiology , Diarrhea/therapy , Enteral Nutrition , Fatal Outcome , Female , Fungemia/drug therapy , Humans , Male , Probiotics/administration & dosage , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Shock, Septic/etiology , Treatment Outcome
2.
